Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence

Autor: Tomás Segura, Ignacio H. Medrano, Sergio Collazo, Claudia Maté, Carlo Sguera, Carlos Del Rio-Bermudez, Hugo Casero, Ignacio Salcedo, Jorge García-García, Cristian Alcahut-Rodríguez, Savana Research Group, Miren Taberna

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative motor neuron disease. Although an early diagnosis is crucial to provide adequate care and improve survival, patients with ALS experience a significant diagnostic delay. This s

Externí odkaz: https://doaj.org/article/f5d177c265924ec68ff08736b9989ed2

Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

Autor: González-Juanatey, Carlos, Anguita-Sánchez, Manuel, Barrios, Vivencio, Núñez-Gil, Iván, Gómez-Doblas, Juan José, García-Moll, Xavier, Lafuente-Gormaz, Carlos, Rollán-Gómez, María Jesús, Peral-Disdier, Vicente, Martínez-Dolz, Luis, Rodríguez-Santamarta, Miguel, Viñolas-Prat, Xavier, Soriano-Colomé, Toni, Muñoz-Aguilera, Roberto, Plaza, Ignacio, Curcio-Ruigómez, Alejandro, Orts-Soler, Ernesto, Segovia, Javier, Fanjul, Víctor, Cequier, Ángel, Savana Research Group

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6004
Scientia

Diabetes mellitus; Natural language processing; Risk factors Diabetis mellitus; Processament del llenguatge natural; Factors de risc Diabetes mellitus; Procesamiento del lenguaje natural; Factores de riesgo Patients with Type 2 diabetes mellitus (T2D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a789e933dfe266ec7d71d9cd793c7a2
https://hdl.handle.net/10668/21357

Safety and Effectiveness of Oral Anticoagulants in Atrial Fibrillation: Real-World Insights Using Natural Language Processing and Machine Learning.

Autor: Cosín-Sales J; Cardiology Department, Arnau de Vilanova Hospital, 46015 Valencia, Spain.; Faculty of Medicine, CEU-Cardenal Herrera University, Alfara del Patriaca, 46115 Valencia, Spain., Anguita Sánchez M; Clinical Management Unit of Cardiology, Reina Sofía University Hospital, 14004 Córdoba, Spain.; Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, 14004 Córdoba, Spain.; Biomedical Research Networking Center in Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain., Suárez C; La Princesa University Hospital, 28006 Madrid, Spain.; La Princesa University Hospital Health Research Institute, 28006 Madrid, Spain.; Faculty of Medicine, Universidad Autónoma of Madrid, 28049 Madrid, Spain., Arias-Cabrales C; Savana Research S.L., 28010 Madrid, Spain., Martínez-Sanchez L; Savana Research S.L., 28010 Madrid, Spain., Savana Research Group; Savana Research S.L., 28010 Madrid, Spain., Arumi D; Medical Department, Pfizer España, 28050 Madrid, Spain., Fernández de Cabo S; Medical Department, Pfizer España, 28050 Madrid, Spain.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Oct 18; Vol. 13 (20). Date of Electronic Publication: 2024 Oct 18.

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain.

Autor: González-Juanatey C; Hospital Universitario Lucus Augusti, 27003 Lugo, Spain., Anguita-Sánchez M; Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, 14014 Cordoba, Spain., Barrios V; Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., Núñez-Gil I; Cardiology Department, Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain.; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain., Gómez-Doblas JJ; IBIMA (Instituto de Investigación Biomédica de Málaga), Hospital Universitario Virgen de la Victoria, CIBERCV (Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares), 29010 Malaga, Spain., García-Moll X; Hospital Universitario Santa Creu i Sant Pau, 08041 Barcelona, Spain., Lafuente-Gormaz C; Hospital Universitario de Albacete, 02006 Albacete, Spain., Rollán-Gómez MJ; Hospital Universitario Río Hortega, 47012 Valladolid, Spain., Peral-Disdier V; Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain., Martínez-Dolz L; Hospital Universitario y Politécnico La Fe, CIBERCV (Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares), IIS La Fe, 46026 Valencia, Spain., Rodríguez-Santamarta M; Hospital Universitario de León, 24071 Leon, Spain., Viñolas-Prat X; Hospital Universitario Santa Creu i Sant Pau, 08041 Barcelona, Spain., Soriano-Colomé T; Hospital Vall d'Hebron, CIBERCV (Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares), 08035 Barcelona, Spain., Muñoz-Aguilera R; Hospital Infanta Leonor, 28031 Madrid, Spain., Plaza I; Hospital Infanta Sofía, 28703 Madrid, Spain., Curcio-Ruigómez A; Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain., Orts-Soler E; Hospital General Universitario de Castellón, 12004 Castellon de la Plana, Spain., Segovia-Cubero J; Hospital Universitario Puerta de Hierro, 28222 Madrid, Spain., Fanjul V; Savana Research SL, 28013 Madrid, Spain., Marín-Corral J; Savana Research SL, 28013 Madrid, Spain., Cequier Á; Hospital Universitario de Bellvitge, IDIBELL (Instituto de Investigación Biomédica de Bellvitge), Universidad de Barcelona, 08007 Barcelona, Spain., Savana Research Group; Savana Research SL, 28013 Madrid, Spain.

Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Aug 10; Vol. 12 (16). Date of Electronic Publication: 2023 Aug 10.